This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Jan 2012

Fleming Pharma Sells Products to Valeant

Fleming Pharmaceuticals has sold rights of several of its products to Valeant International.

US-based Fleming Pharmaceuticals has sold its rights to its branded Ocean, Nephrocaps, Magonate and ProBarimin QT products to Valeant International SRL.


Valeant has appointed its affiliate, Valeant Pharmaceuticals North America LLC, to distribute these products in the U.S.


Fleming also manufactures contract products for a broad customer base, including the federal government. Fleming has retained rights to manufacture and market ThyroShield, one of two FDA-approved potassium iodide medicines used in nuclear emergencies to block the absorption of radioactive iodine to avoid thyroid cancer.


In addition, Fleming has retained its contract services business relating

Related News